3-130092182-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136152.1(ALG1L2):c.213C>A(p.His71Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,612,338 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001136152.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG1L2 | NM_001136152.1 | c.213C>A | p.His71Gln | missense_variant | 3/8 | ENST00000425059.1 | NP_001129624.1 | |
LINC02014 | NR_146710.1 | n.158-315G>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG1L2 | ENST00000425059.1 | c.213C>A | p.His71Gln | missense_variant | 3/8 | 5 | NM_001136152.1 | ENSP00000479850.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 247194Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134412
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460122Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726380
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.213C>A (p.H71Q) alteration is located in exon 3 (coding exon 3) of the ALG1L2 gene. This alteration results from a C to A substitution at nucleotide position 213, causing the histidine (H) at amino acid position 71 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at